ZSquare Ltd.

ZSquare Ltd. is a medical technology company specializing in the development of innovative single-use endoscopes that enhance patient safety and operational efficiency in healthcare by reducing the risks associated with reusable devices. Founded in 2013 and headquartered in Petah Tikva, Israel, ZSquare Ltd. develops advanced single-use endoscopic solutions.

The company has raised a total of USD 15. 00 mn in funding, with the latest round occurring in March 2022 led by Chartered Group. ZSquare operates with a focus on expanding its product range and enhancing existing technologies. ZSquare develops innovative single-use endoscopes characterized by ultra-thin, high-resolution, and flexible designs.

Their patented fiber technology minimizes the optical component's diameter without compromising image quality, allowing for advanced visualizations in urology, gastroenterology, ENT, bronchoscopy, and gynecology. ZSquare addresses issues like cross-contamination found in reusable endoscopes, targeting hospitals and healthcare providers in North America and Europe to improve access to quality diagnostic tools. ZSquare's revenue model is based on direct sales of its single-use endoscopic products to healthcare institutions. The transactions are primarily B2B, with healthcare providers purchasing endoscopes to ensure high-performance diagnostics while mitigating risks related to reusable equipment.

Their flagship product, the ENT-FLEX™ single-use rhin laryngoscope, reflects their commitment to innovation and is priced to accommodate both bulk and individual purchases. In March 2022, ZSquare Ltd. raised USD 15. 00 mn in venture funding led by Chartered Group.

The funding will support the soft launch of its disruptive single-use ENT endoscope and further research and development for expanding applications. The company aims to penetrate new markets, focusing on enhancing its product offerings and expanding its reach in various medical specialties.